Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vascular Biogen. Ord (VBLT)

Vascular Biogen. Ord (VBLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,112
  • Shares Outstanding, K 77,640
  • Annual Sales, $ 660 K
  • Annual Income, $ -32,300 K
  • 60-Month Beta 0.76
  • Price/Sales 20.18
  • Price/Cash Flow N/A
  • Price/Book 0.57
Trade VBLT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.21
  • Most Recent Earnings $-0.01 on 08/14/23
  • Latest Earnings Date 11/13/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1526 +2.23%
on 10/16/23
0.2880 -45.83%
on 10/12/23
-0.0780 (-33.33%)
since 09/15/23
3-Month
0.1526 +2.23%
on 10/16/23
0.3098 -49.64%
on 07/25/23
-0.1383 (-46.99%)
since 07/14/23
52-Week
0.1009 +54.61%
on 12/19/22
0.3200 -51.25%
on 07/13/23
+0.0250 (+19.08%)
since 10/14/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBLT, DM, AAIC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

VBLT : 5.4600 (-8.77%)
DM : 0.8800 (+1.15%)
AAIC : 4.84 (+1.47%)
Vascular Biogenics: Q2 Earnings Snapshot

Vascular Biogenics: Q2 Earnings Snapshot

VBLT : 5.4600 (-8.77%)
Vascular Biogenics: Q1 Earnings Snapshot

Vascular Biogenics: Q1 Earnings Snapshot

VBLT : 5.4600 (-8.77%)
INVESTIGATION ALERT: Halper Sadeh LLC Investigates KBAL, DSEY, VBLT, BTE

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

KBAL : 12.30 (-0.89%)
DSEY : 8.39 (unch)
VBLT : 5.4600 (-8.77%)
BTE : 3.63 (+3.71%)
Moore Kuehn Encourages DCT, PTRS, VBLT, and WAYN Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

DCT : 18.99 (unch)
PTRS : 7.15 (+0.99%)
VBLT : 5.4600 (-8.77%)
Aleph Farms Increases Production Capabilities with VBL Therapeutics Facility Acquisition and ESCO Aster Partnership

Aleph Farms , the first company to grow cultivated steaks directly from non-modified cow cells, today announced that it has acquired a manufacturing facility in Modi’in, Israel, and certain related assets...

VBLT : 5.4600 (-8.77%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROCC, BTE, ADMP, VBLT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ROCC : 37.47 (-1.96%)
BTE : 3.63 (+3.71%)
ADMP : 0.7751 (+0.86%)
VBLT : 5.4600 (-8.77%)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Vascular Biogenics Ltd. - VBLT

/PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national...

VBLT : 5.4600 (-8.77%)
VASCULAR BIOGENICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vascular Biogenics Ltd. - VBLT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Vascular Biogenics Ltd. operating as VBL...

VBLT : 5.4600 (-8.77%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INFI, HRZN, VBLT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

INFI : 0.0080 (-50.00%)
HRZN : 11.37 (+1.16%)
VBLT : 5.4600 (-8.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Vascular Biogenics Ltd. is a clinical stage biotechnology company. It is focused on the discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead oncology candidate VB-111, is a gene-based biologic which is in Phase II clinical trials for the treatment...

See More

Key Turning Points

3rd Resistance Point 0.2214
2nd Resistance Point 0.2069
1st Resistance Point 0.1815
Last Price 5.4600
1st Support Level 0.1416
2nd Support Level 0.1271
3rd Support Level 0.1017

See More

Last Price 5.4600
52-Week High 0.3200
Fibonacci 61.8% 0.2363
Fibonacci 50% 0.2104
Fibonacci 38.2% 0.1846
52-Week Low 0.1009

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar